Download presentation
Presentation is loading. Please wait.
1
Risk of fetal malformation
Maternal illness Risk of fetal malformation
2
Maternal illness Key areas
Does the condition itself produce risk? Does illness presenting during pregnancy produce risk? Risks of treatment v risk of disease
3
Pre-existing disease and risk of malformation
Diabetes Respiratory disease Renal disease Neurological disease Hypertensive disease Connective tissue disease Endocrine disease Haematological disease
4
Diabetes Rate of major malformations 41.8 per 1000 (CEMACH 2005)
Excess of neural tube defects Excess of congenital heart defects Disproportionately high rate of conotruncal abnormalities Type 1 and Type 2 diabetes
5
Diabetes Clear relationship between degree of periconception control and malformation rate Near linear relation between HbA1c and risk malformation Mechanism of production of malformation not simple Both hyper and hypoglycaemia may be involved
6
Endocrine disease Undiagnosed hypothyroidism in the first trimester and microcephaly Is it real? Fetal thyrotoxicosis Rare but preventable cause of hydrops Fetal goitre Differential diagnosis of neck mass
7
Fetal goitre
8
Respiratory disease Asthma Cystic fibrosis Pneumonia
No known link between disease and malformation Cystic fibrosis Other than risk CF, no obvious additional risk from respiratory problems of disease itself Pneumonia Exclude VZV, HIV
9
Renal disease No data that links renal disease itself with increased risk of congenital malformation Specific causes of renal disease may increase risk fetal malformation Adult polycystic disease Familial renal dysplasia Chronic pyelonephritis/reflux and family history Apert’s disease and other rare genetic causes Always make sure you know aetiology of renal disease
10
Neurological disorders
Epilepsy Unless genetic or syndromal cause, epilepsy itself does not increase risk Watch for rare causes such as Neurofibromatosis, tuberosclerosis
11
Neurological disorders
Multiple sclerosis Muscular dystrophies Neurodegenerative disease Other than genetic recurrence risks no known association
12
Haematological disease
Haemoglobinopathies Allo-immune disease Cancer
13
Haemoglobinopathy Differential diagnosis of hydrops/ascites
14
Allo-immune disease Differential Hydrops Brain malformation
15
Connective tissue disease
Rheumatoid arthritis SLE Behcet’s disease Sjogren’s syndrome
16
Anti-RNA antibodies Ro and La
Antibodies most likely where SLE or Sjogren’s syndrome or where unspecified disease Risk of congenital heart block 2% of anti-Ro, 3% if both Up to 40% mortality in first year Small risk structural disease
17
New maternal illness during pregnancy
Syphilis Viral infection Various congenital syndromes Conditions causing hypoxia Risk of acquired cerebral malformation Risk of ischaemic lesions (gut, renal)
18
Therapeutic drugs and malformation
What data is available from animal studies and how applicable is this? Are there theoretical reasons why the drug might be harmful even if no data? What are the human data and how was it collected? Are there alternatives that might be safer? What are the risks to mother and fetus of stopping/changing?
19
Examples of bad science
Steroids and cleft Animal work, wrong steroid, placental barrier Metformin Never proven risk, blanket ban may have actually increased risk in type 2 diabetes Anticonvulsants Reassuring animal work not translated to human studies
20
Consequences of stopping
ACE inhibitors and diabetic nephropathy Antithyroid medication Anti-cytokine agents in SLE or asthma Immunosuppressants and transplant
21
Maternal disease and malformation
Rarely directly implicated Ensure know aetiology of individual disease Interaction with therapy
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.